Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSCG | ISIN: US00510M1045 | Ticker-Symbol: 3ZO
Tradegate
27.06.25 | 16:15
0,400 Euro
+4,85 % +0,019
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ACURX PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ACURX PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,3700,39028.06.
0,3750,38827.06.

Aktuelle News zur ACURX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.06.Acurx Pharmaceuticals, Inc. - 8-K, Current Report6
17.06.Acurx Pharmaceuticals, Inc.: Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI263As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained...
► Artikel lesen
21.05.Acurx files to sell 10.9M shares of common stock for holders12
21.05.Acurx Pharmaceuticals, Inc. - S-1, General form for registration of securities2
ACURX PHARMACEUTICALS Aktie jetzt für 0€ handeln
15.05.H.C. Wainwright sets $8 target for Acurx Pharmaceuticals stock17
13.05.Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment3
13.05.Acurx Pharmaceuticals GAAP EPS of -$0.113
13.05.Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update67STATEN ISLAND, N.Y., May 13, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company...
► Artikel lesen
12.05.Acurx Pharmaceuticals, Inc. - 10-Q, Quarterly Report-
12.05.A Look Ahead: Acurx Pharmaceuticals' Earnings Forecast4
08.05.Acurx Pharmaceuticals, Inc. - 8-K, Current Report3
17.04.Acurx Pharmaceuticals erhält Patent in Indien für Antibiotika4
16.04.New to The Street Renews Acurx Pharmaceuticals for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach292NEW YORK CITY, NEW YORK / ACCESS Newswire / April 16, 2025 / New to The Street, a premier business television and media platform, is proud to announce the renewal of its media partnership with Acurx...
► Artikel lesen
18.03.Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update320STATEN ISLAND, N.Y., March 18, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical...
► Artikel lesen
18.03.Acurx Pharmaceuticals, Inc Full Year Loss Narrows2
18.03.Acurx Pharmaceuticals, Inc. - 8-K, Current Report2
18.03.Acurx Pharmaceuticals GAAP EPS of -$0.874
17.03.Acurx Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
17.03.Acurx Pharmaceuticals, Inc. - 10-K, Annual Report2
14.03.New to The Street & Sight & Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP375NEW YORK CITY, NY / ACCESS Newswire / March 14, 2025 / The highly anticipated Visionaries Series from New to The Street and Sight & Sound premieres tomorrow on Bloomberg at 6:30 PM EST as sponsored...
► Artikel lesen
Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1